• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
117.1064173
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
69.55
17401.07
EPS(TTM)
Face Value()
Div & Yield %
6.54
1
0
 

hcl technologies ltd
Indo Count Industries consolidated net profit rises 14.96% in the March 2026 quarter
Jun 01,2026
Net profit of Indo Count Industries rose 14.96% to Rs 24.20 crore in the quarter ended March 2026 as against Rs 21.05 crore during the previous quarter ended March 2025. Sales rose 3.43% to Rs 1057.68 crore in the quarter ended March 2026 as against Rs 1022.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 49.33% to Rs 126.68 crore in the year ended March 2026 as against Rs 250.00 crore during the previous year ended March 2025. Sales declined 0.24% to Rs 4141.35 crore in the year ended March 2026 as against Rs 4151.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1057.681022.56 3 4141.354151.39 0
OPM %8.168.78 -9.4612.94 -
PBDT72.7659.60 22 325.43453.58 -28
PBT30.1625.54 18 166.25337.65 -51
NP24.2021.05 15 126.68250.00 -49